Simon Cervenka

About me
Publications
CV
Public outreach and news

About me

I am an associate professor and senior clinical lecturer in psychiatry at KI,
and consultant in Psychiatry at Psykiatri Nordväst. Since 2018, I am
leading a multidisciplinary research group focusing on molecular imaging
and psychosis research.
Medical degree, Uppsala University, 1999
Licence to practice medicine, 2002
PhD, Department of Clinical Neuroscience, Karolinska Institutet, 2008
Specialist in General Psychiatry, 2009
Guest Researcher, University of Cambridge, 2015-2016
Associate Professor in Psychiatry, 2016

Research

My research is dedicated to finding new methods of diagnosis and treatment of
psychotic disorders. The main approach is to use Positron Emission
Tomography (PET) but extending also to other imaging modalities and
methods. The research is carried out within Centre for Psychiatry
Research, in close collaboration with health care partners.

Teaching

I am responsible for the psychiatry course at the MD programme at Karolinska
Institutet, site Solna.

Articles

Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2023;111:376-385
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity
Eren F; Schwieler L; Orhan F; Malmqvist A; Piehl F; Cervenka S; Sellgren CM; Fatouros-Bergman H; Engberg G; Erhardt S
Article: ADDICTION. 2023;118(6):1053-1061
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers
Jangard S; Jayaram-Lindstrom N; Isacsson NH; Matheson GJ; Plaven-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(14):e2213880120
Large- scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Schijven D; Postema MC; Fukunaga M; Matsumoto J; Miura K; de Zwarte SMC; van Haren NEM; Cahn W; Pol HEH; Kahn RS; Ayesa-Arriola R; de la Foz VO-G; Tordesillas-Gutierrez D; Vazquez-Bourgon J; Crespo-Facorro B; Alnaes D; Dahl A; Westlye LT; Agartz I; Andreassen OA; Jonsson EG; Kochunov P; Bruggemann JM; Catts SV; Michie PT; Mowry BJ; Quide Y; Rasser PE; Schall U; Scott RJ; Carr VJ; Green MJ; Henskens FA; Loughland CM; Pantelis C; Weickert CS; Weickert TW; De Haan L; Brosch K; Pfarr J-K; Ringwald KG; Stein F; Jansen A; Kircher TTJ; Nenadic I; Kramer B; Gruber O; Satterthwaite TD; Bustillo J; Mathalon DH; Preda A; Calhoun VD; Ford JM; Potkin SG; Chen J; Tan Y; Wang Z; Xiang H; Fan F; Bernardoni F; Ehrlich S; Fuentes-Claramonte P; Garcia-Leon MA; Guerrero-Pedraza A; Salvador R; Sarro S; Pomarol-Clotet E; Ciullo V; Piras F; Vecchio D; Banaj N; Spalletta G; Michielse S; van Amelsvoort T; Dickie EW; Voineskos AN; Sim K; Ciufolini S; Dazzan P; Murray RM; Kim W-S; Chung Y-C; Andreou C; Schmidt A; Borgwardt S; McIntosh AM; Whalley HC; Lawrie SM; Du Plessis S; Luckhoff HK; Scheffler F; Emsley R; Grotegerd D; Lencer R; Dannlowski U; Edmond JT; Rootes-Murdy K; Stephen JM; Mayer AR; Antonucci LA; Fazio L; Pergola G; Bertolino A; Diaz-Caneja CM; Janssen J; Lois NG; Arango C; Tomyshev AS; Lebedeva I; Cervenkav S; Sellgrenv CM; Georgiadis F; Kirschner M; Kaiser S; Hajek T; Skoch A; Spaniel F; Kim M; Bin Kwak Y; Oh S; Kwon JS; James A; Bakker G; Knochel C; Stablein M; Oertel V; Uhlmann A; Howells FM; Stein DJ; Temmingh HS; Diaz-Zuluaga AM; Pineda-Zapata JA; Lopez-Jaramillo C; Homan S; Ji E; Surbeck W; Homan P; Fishera SE; Franke B; Glahn DC; Gur RC; Hashimoto R; Jahanshad N; Luders E; Medland SE; Thompson PM; Turner JA; van Erp TGM; Francks C
Article: CLINICAL PSYCHOLOGY AND PSYCHOTHERAPY. 2023;30(2):486-490
Metacognitive training for negative symptoms: Support for the cognitive model
Swanson L; Griffiths H; Moritz S; Cervenka S
Article: NATURE COMMUNICATIONS. 2022;13(1):6427
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia
Gracias J; Orhan F; Horbeck E; Holmen-Larsson J; Khanlarkani N; Malwade S; Goparaju SK; Schwieler L; Demirel IS; Fu T; Fatourus-Bergman H; Pelanis A; Goold CP; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yanez VAC; Gopfert JC; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan SD; Perlis RH; Cervenka S; Erhardt S; Landen M; Sellgren CM
Article: HELIYON. 2022;8(9):e10424
Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms
Larsson C; Lee M; Lundgren T; Erhardt S; Sellgren CM; Cervenka S; Borg J; Bolte S; Fatouros-Bergman H
Article: MOLECULAR PSYCHIATRY. 2022;27(8):3247-3261
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
Matlik K; Garton DR; Montano-Rodriguez AR; Olfat S; Eren F; Casserly L; Damdimopoulos A; Panhelainen A; Porokuokka LL; Kopra JJ; Turconi G; Schweizer N; Bereczki E; Piehl F; Engberg G; Cervenka S; Piepponen TP; Zhang F-P; Sipila P; Jakobsson J; Sellgren CM; Erhardt S; Andressoo J-O
Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2022;151:571-574
Cytomegalovirus infection associated with lower IQ in adolescent patients with schizophrenia spectrum disorders: A preliminary report
Calkova T; Cervenka S; Yolken RH; Andreassen OA; Andreou D
Article: TRANSLATIONAL PSYCHIATRY. 2022;12(1):229
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
Shang P; Ho AM-C; Tufvesson-Alm M; Lindberg DR; Grant CW; Orhan F; Eren F; Bhat M; Engberg G; Schwieler L; Fatouros-Bergman H; Imbeault S; Iverson RM; Dasari S; Piehl F; Cervenka S; Sellgren CM; Erhardt S; Choi D-S
Article: MOLECULAR PSYCHIATRY. 2022;27(2):1233-1240
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
Plaven-Sigray P; Ikonen Victorsson P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Sellgren CM; Erhardt S; Agartz I; Halldin C; Farde L; Cervenka S
Article: HUMAN BRAIN MAPPING. 2022;43(1):352-372
A meta-analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium
Gutman BA; van Erp TGM; Alpert K; Ching CRK; Isaev D; Ragothaman A; Jahanshad N; Saremi A; Zavaliangos-Petropulu A; Glahn DC; Shen L; Cong S; Alnaes D; Andreassen OA; Nhat TD; Westlye LT; Kochunov P; Satterthwaite TD; Wolf DH; Huang AJ; Kessler C; Weideman A; Nguyen D; Mueller BA; Faziola L; Potkin SG; Preda A; Mathalon DH; Bustillo J; Calhoun V; Ford JM; Walton E; Ehrlich S; Ducci G; Banaj N; Piras F; Piras F; Spalletta G; Canales-Rodriguez EJ; Fuentes-Claramonte P; Pomarol-Clotet E; Radua J; Salvador R; Sarro S; Dickie EW; Voineskos A; Tordesillas-Gutierrez D; Crespo-Facorro B; Setien-Suero E; van Son JM; Borgwardt S; Schoenborn-Harrisberger F; Morris D; Donohoe G; Holleran L; Cannon D; McDonald C; Corvin A; Gill M; Busatto Filho G; Rosa PGP; Serpa MH; Zanetti MV; Lebedeva I; Kaleda V; Tomyshev A; Crow T; James A; Cervenka S; Sellgren CM; Fatouros-Bergman H; Agartz I; Howells F; Stein DJ; Temmingh H; Uhlmann A; de ZGI; McMahon KL; Wright M; Cobia D; Csernansky JG; Thompson PM; Turner JA; Wang L
Article: HUMAN BRAIN MAPPING. 2022;43(1):431-451
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years
Frangou S; Modabbernia A; Williams SCR; Papachristou E; Doucet GE; Agartz I; Aghajani M; Akudjedu TN; Albajes-Eizagirre A; Alnaes D; Alpert KI; Andersson M; Andreasen NC; Andreassen OA; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buitelaar JK; Busatto GF; Buckner RL; Calhoun V; Canales-Rodriguez EJ; Cannon DM; Caseras X; Castellanos FX; Cervenka S; Chaim-Avancini TM; Ching CRK; Chubar V; Clark VP; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EA; Dale AM; Davey C; de Geus EJC; de Haan L; de ZGI; den Braber A; Dickie EW; Di Giorgio A; Nhat TD; Dorum ES; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher SE; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn DC; Gotlib IH; Grabe H-J; Grimm O; Groenewold NA; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Harrison BJ; Hartman CA; Hatton SN; Heinz A; Heslenfeld DJ; Hibar DP; Hickie IB; Ho B-C; Hoekstra PJ; Hohmann S; Holmes AJ; Hoogman M; Hosten N; Howells FM; Pol HEH; Huyser C; Jahanshad N; James A; Jernigan TL; Jiang J; Jonsson EG; Joska JA; Kahn R; Kalnin A; Kanai R; Klein M; Klyushnik TP; Koenders L; Koops S; Kraemer B; Kuntsi J; Lagopoulos J; Lazaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin NG; Martinez-Zalacain I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald BC; McIntosh AM; McMahon KL; McPhilemy G; Menchon JM; Medland SE; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik JE; Nyberg L; Oosterlaan J; de la Foz VO-G; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella MJ; Potkin SG; Radua J; Reif A; Rinker DA; Roffman JL; Rosa PGP; Sacchet MD; Sachdev PS; Salvador R; Sanchez-Juan P; Sarro S; Satterthwaite TD; Saykin AJ; Serpa MH; Schmaal L; Schnell K; Schumann G; Sim K; Smoller JW; Sommer I; Soriano-Mas C; Stein DJ; Strike LT; Swagerman SC; Tamnes CK; Temmingh HS; Thomopoulos SI; Tomyshev AS; Tordesillas-Gutierrez D; Trollor JN; Turner JA; Uhlmann A; van den Heuvel OA; van den Meer D; van der Wee NJA; van Haren NEM; van't Ent D; van Erp TGM; Veer IM; Veltman DJ; Voineskos A; Voelzke H; Walter H; Walton E; Wang L; Wang Y; Wassink TH; Weber B; Wen W; West JD; Westlye LT; Whalley H; Wierenga LM; Wittfeld K; Wolf DH; Worker A; Wright MJ; Yang K; Yoncheva Y; Zanetti MV; Ziegler GC; Thompson PM; Dima D
Article: HUMAN BRAIN MAPPING. 2022;43(1):452-469
Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years
Dima D; Modabbernia A; Papachristou E; Doucet GE; Agartz I; Aghajani M; Akudjedu TN; Albajes-Eizagirre A; Alnaes D; Alpert KI; Andersson M; Andreasen NC; Andreassen OA; Asherson P; Banaschewski T; Bargallo N; Baumeister S; Baur-Streubel R; Bertolino A; Bonvino A; Boomsma DI; Borgwardt S; Bourque J; Brandeis D; Breier A; Brodaty H; Brouwer RM; Buitelaar JK; Busatto GF; Buckner RL; Calhoun V; Canales-Rodriguez EJ; Cannon DM; Caseras X; Castellanos FX; Cervenka S; Chaim-Avancini TM; Ching CRK; Chubar V; Clark VP; Conrod P; Conzelmann A; Crespo-Facorro B; Crivello F; Crone EA; Dale AM; Davey C; de Geus EJC; de Haan L; de ZGI; den Braber A; Dickie EW; Di Giorgio A; Nhat TD; Dorum ES; Ehrlich S; Erk S; Espeseth T; Fatouros-Bergman H; Fisher SE; Fouche J-P; Franke B; Frodl T; Fuentes-Claramonte P; Glahn DC; Gotlib IH; Grabe H-J; Grimm O; Groenewold NA; Grotegerd D; Gruber O; Gruner P; Gur RE; Gur RC; Harrison BJ; Hartman CA; Hatton SN; Heinz A; Heslenfeld DJ; Hibar DP; Hickie IB; Ho B-C; Hoekstra PJ; Hohmann S; Holmes AJ; Hoogman M; Hosten N; Howells FM; Pol HEH; Huyser C; Jahanshad N; James A; Jernigan TL; Jiang J; Jonsson EG; Joska JA; Kahn R; Kalnin A; Kanai R; Klein M; Klyushnik TP; Koenders L; Koops S; Kraemer B; Kuntsi J; Lagopoulos J; Lazaro L; Lebedeva I; Lee WH; Lesch K-P; Lochner C; Machielsen MWJ; Maingault S; Martin NG; Martinez-Zalacain I; Mataix-Cols D; Mazoyer B; McDonald C; McDonald BC; McIntosh AM; McMahon KL; McPhilemy G; Menchon JM; Medland SE; Meyer-Lindenberg A; Naaijen J; Najt P; Nakao T; Nordvik JE; Nyberg L; Oosterlaan J; Ortiz-Garcia De la Foz V; Paloyelis Y; Pauli P; Pergola G; Pomarol-Clotet E; Portella MJ; Potkin SG; Radua J; Reif A; Rinker DA; Roffman JL; Rosa PGP; Sacchet MD; Sachdev PS; Salvador R; Sanchez-Juan P; Sarro S; Satterthwaite TD; Saykin AJ; Serpa MH; Schmaal L; Schnell K; Schumann G; Sim K; Smoller JW; Sommer I; Soriano-Mas C; Stein DJ; Strike LT; Swagerman SC; Tamnes CK; Temmingh HS; Thomopoulos SI; Tomyshev AS; Tordesillas-Gutierrez D; Trollor JN; Turner JA; Uhlmann A; van den Heuvel OA; van den Meer D; van der Wee NJA; van Haren NEM; Van't Ent D; van Erp TGM; Veer IM; Veltman DJ; Voineskos A; Voelzke H; Walter H; Walton E; Wang L; Wang Y; Wassink TH; Weber B; Wen W; West JD; Westlye LT; Whalley H; Wierenga LM; Williams SCR; Wittfeld K; Wolf DH; Worker A; Wright MJ; Yang K; Yoncheva Y; Zanetti MV; Ziegler GC; Thompson PM; Frangou S
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):566
Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
Theorell J; Ramberger M; Harrison R; Mgbachi V; Jacobson L; Waters P; Erhardt S; Sellgren CM; Cervenka S; Piehl F; Irani SR
Article: MOLECULAR PSYCHIATRY. 2021;26(11):6820-6832
GRK3 deficiency elicits brain immune activation and psychosis
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schullman A; Goiny M; Svensson CI; Hokfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landen M; Engberg G; Erhardt S
Article: NPJ SCHIZOPHRENIA. 2021;7(1):46
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
Lee M; Fatouros-Bergman H; Plaven-Sigray P; Victorsson PI; Sellgren CM; Erhardt S; Flyckt L; Farde L; Cervenka S
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(5):315-322
Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences
Taipale H; Puranen A; Mittendorfer-Rutz E; Tiihonen J; Tanskanen A; Cervenka S; Lahteenvuo M
Article: SCIENTIFIC REPORTS. 2021;11(1):7527
Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
Becklen M; Orhan F; Piehl F; Cervenka S; Sellgren CM; Flyckt L; Erhardt S; Fatouros-Bergman H
Article: JOURNAL OF NUCLEAR MEDICINE. 2021;62(3):412-417
Nondisplaceable Binding Is a Potential Confounding Factor in ¹¹C-PBR28 Translocator Protein PET Studies
Laurell GL; Plaven-Sigray P; Jucaite A; Varrone A; Cosgrove KP; Svarer C; Knudsen GM; Ogden RT; Zanderigo F; Cervenka S; Hillmer AT; Schain M
Article: NEUROIMAGE. 2021;226:117523
Low convergent validity of [¹¹C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [¹¹C]FLB 457
Freiburghaus T; Svensson JE; Matheson GJ; Plaven-Sigray P; Lundberg J; Farde L; Cervenka S
Article: NATURE AND SCIENCE OF SLEEP. 2021;13:775-789
Objective and Subjective Sleep in Rheumatoid Arthritis and Severe Seasonal Allergy: Preliminary Assessments of the Role of Sickness, Central and Peripheral Inflammation
Tamm S; Lensmar C; Andreasson A; Axelsson J; Moren AF; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Hoglund CO; Strand V; Cervenka S; Lekander M
Article: BIOLOGICAL PSYCHIATRY: COGNITIVE NEUROSCIENCE AND NEUROIMAGING. 2020;5(12):1095-1103
Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study
Tonnesen S; Kaufmann T; de Lange A-MG; Richard G; Nhat TD; Alnaes D; van der Meer D; Rokicki J; Moberget T; Maximov II; Agartz I; Aminoff SR; Beck D; Barch DM; Beresniewicz J; Cervenka S; Fatouros-Bergman H; Craven AR; Flyckt L; Gurholt TP; Haukvik UK; Hugdahl K; Johnsen E; Jonsson EG; Kolskar KK; Kroken RA; Lagerberg TV; Loberg E-M; Nordvik JE; Sanders A-M; Ulrichsen K; Andreassen OA; Westlye LT
Article: EJNMMI RESEARCH. 2020;10(1):95
Reliability of dopamine transporter PET measurements with [¹⁸F]FE-PE2I in patients with Parkinson's disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Article: NATURE COMMUNICATIONS. 2020;11(1):4016
The genetic architecture of human brainstem structures and their involvement in common brain disorders
Elvsashagen T; Bahrami S; van der Meer D; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Beyer MK; Blasi G; Borgwardt S; Boye B; Buitelaar J; Boen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Di Carlo P; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman CA; Haberg A; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jonassen R; Jonsson EG; Kirsch P; Kloszewska I; Lagerberg TV; Landro NI; Le Hellard S; Lesch K-P; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; O'Connell KS; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin AA; Schmidt A; Schwarz E; Selbaek G; Soininen H; Sowa P; Steen VM; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Kaufmann T; Farde L; Flyckt L; Engberg G; Erhardt SS; Fatouros-Bergman H; Cervenka S; Schwieler L; Piehl F; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F; Sellgren CM
Article: SCHIZOPHRENIA RESEARCH. 2020;222:175-184
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plaven-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):77
Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(12):1756-1761
Synthesis and Preclinical Evaluation of 6-[¹⁸F]Fluorine-α- methyl-L-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake
Krasikova R; Kondrashov M; Avagliano C; Petukhov M; Vazquez-Romero A; Revunov E; Johnstrom P; Tari L; Toth M; Haggkvist J; Erhardt S; Cervenka S; Schou M
Article: IBRO REPORTS. 2020;8:136-142
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
Xu C; Sellgren CM; Fatouros-Bergman H; Piehl F; Blennow K; Zetterberg H; Brinkmalm A; Santillo AF; Lundgren S; Cervenka S; Engberg G; Erhardt S
Article: NEUROIMAGE. 2019;202:116143
Validity and reliability of extrastriatal [¹¹C]raclopride binding quantification in the living human brain
Svensson JE; Schain M; Plaven-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(11):2329-2338
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [¹¹C]PBR28 HRRT PET study
Tuisku J; Plaven-Sigray P; Gaiser EC; Airas L; Al-Abdulrasul H; Bruck A; Carson RE; Chen M-K; Cosgrove KP; Ekblad L; Esterlis I; Farde L; Forsberg A; Halldin C; Helin S; Kosek E; Lekander M; Lindgren N; Marjamaki P; Rissanen E; Sucksdorff M; Varrone A; Collste K; Gallezot J-D; Hillmer A; Huang Y; Hoglund CO; Johansson J; Jucaite A; Lampa J; Nabulsi N; Pittman B; Sandiego CM; Stenkrona P; Rinne J; Matuskey D; Cervenka S
Article: NATURE NEUROSCIENCE. 2019;22(10):1617-1623
Common brain disorders are associated with heritable patterns of apparent aging of the brain
Kaufmann T; van der Meer D; Nhat TD; Schwarz E; Lund MJ; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Boen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Cordova-Palomera A; Dale AM; de Quervain DJF; Carlo P; Djurovic S; Dorum ES; Eisenacher S; Elvsashagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Haberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jernigan TL; Jonassen R; Jonsson EG; Kirsch P; Ktoszewska I; Kolskar KK; Landro NI; Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbaek G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Farde L; Flyckts L; Engberg G; Erhardt S; Fatouros-Bergmann H; Schwieler L; Piehl F; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: JOURNAL OF NEUROIMMUNOLOGY. 2019;334:577000
Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [¹¹C]PBR28 positron emission tomography
Forsberg A; Lampa J; Estelius J; Cervenka S; Farde L; Halldin C; Lekander M; Hoglund OC; Kosek E
Article: SCHIZOPHRENIA RESEARCH. 2019;210:221-227
Increased peripheral levels of TARC/CCL17 in first episode psychosis patients
Malmqvist A; Schwieler L; Orhan F; Fatouros-Bergman H; Bauer M; Flyckt L; Cervenka S; Engberg G; Piehl F; Erhardt S; Farde L; Flyckt L; Engberg G; Erhardt S; Fatouros-Bergman H; Cervenka S; Schwieler L; Piehl F; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: JAMA PSYCHIATRY. 2019;76(7):739-748
Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
Alnaes D; Kaufmann T; van der Meer D; Cordova-Palomera A; Rokicki J; Moberget T; Bettella F; Agartz I; Barch DM; Bertolino A; Brandt CL; Cervenka S; Djurovic S; Nhat TD; Eisenacher S; Fatouros-Bergman H; Flyckt L; Di Giorgio A; Haatveit B; Jonsson EG; Kirsch P; Lund MJ; Meyer-Lindenberg A; Pergola G; Schwarz E; Smeland OB; Quarto T; Zink M; Andreassen OA; Westlye LT; Farde L; Collste K; Victorsson P; Engberg G; Erhardt S; Malmqvist A; Hedberg M; Orhan F; Sellgren CM; Schwieler L; Piehl F
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(7):415-425
D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Article: NEUROIMAGE. 2019;188:102-110
Accuracy and reliability of [¹¹C]PBR28 specific binding estimated without the use of a reference region
Plaven-Sigray P; Schain M; Zanderigo F; Farde L; Halldin C; Forsberg A; Varrone A; Jucaite A; Cervenka S; Stenkrona P; Collste K; Kander M; Kosek E; Lampa J; Hoglund CO; Rabiner EA; Gunn RN; Ogden RT; Cervenk S
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):12
Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder
Schwarz E; Nhat TD; Pergola G; Westlye LT; Kaufmann T; Wolfers T; Brecheisen R; Quarto T; Ing AJ; Di Carlo P; Gurholt TP; Harms RL; Noirhomme Q; Moberget T; Agartz I; Andreassen OA; Bellani M; Bertolino A; Blasi G; Brambilla P; Buitelaar JK; Cervenka S; Flyckt L; Frangou S; Franke B; Hall J; Heslenfeld DJ; Kirsch P; McIntosh AM; Noethen MM; Papassotiropoulos A; de Quervain DJ-F; Rietschel M; Schumann G; Tost H; Witt SH; Zink M; Meyer-Lindenberg A; Bettella F; Brandt CL; Clarke T-K; Coynel D; Degenhardt F; Djurovic S; Eisenacher S; Fastenrath M; Fatouros-Bergman H; Forstner AJ; Frank J; Gambi F; Gelao B; Geschwind L; Di Giannantonio M; Di Giorgio A; Hartman CA; Heilmann-Heimbach S; Herms S; Hoekstra PJ; Hoffmann P; Hoogman M; Jonsson EG; Loos E; Maggioni E; Oosterlaan J; Papalino M; Rampino A; Romaniuk L; Selvaggi P; Sepede G; Sonderby IE; Spalek K; Sussmann JE; Thompson PM; Vasquez AA; Vogler C; Whalley H; Farde L; Flyckt L; Engberg G; Erhardt S; Fatouros-Bergman H; Cervenka S; Schwieler L; Agartz I; Collste K; Victorsson P; Malmqvist A; Hedberg M; Orhan F
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2019;75:72-83
Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation
Albrecht DS; Forsberg A; Sandstrom A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Hoglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
Article: EJNMMI RESEARCH. 2018;8(1):102
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plaven-Sigray P; Matheson GJ; Cselenyi Z; Jucaite A; Farde L; Cervenka S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(9):644-654
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Bustillo JR; Clark VP; Agartz I; Mueller BA; Cahn W; de Zwarte SMC; Pol HEH; Kahn RS; Ophoff RA; van Haren NEM; Andreassen OA; Dale AM; Nhat TD; Gurholt TP; Hartberg CB; Haukvik UK; Jorgensen KN; Lagerberg TV; Melle I; Westlye LT; Gruber O; Kraemer B; Richter A; Zilles D; Calhoun VD; Crespo-Facorro B; Roiz-Santianez R; Tordesillas-Gutierrez D; Loughland C; Carr VJ; Catts S; Cropley VL; Fullerton JM; Green MJ; Henskens FA; Jablensky A; Lenroot RK; Mowry BJ; Michie PT; Pantelis C; Quide Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Weickert CS; Weickert TW; Morris DW; Hong E; Kochunov P; Beard LM; Gur RE; Gur RC; Satterthwaite TD; Wolf DH; Belger A; Brown GG; Ford JM; Macciardi F; Mathalon DH; O'Leary DS; Potkin SG; Preda A; Voyvodic J; Lim KO; McEwen S; Yang F; Tan Y; Tan S; Wang Z; Fan F; Chen J; Xiang H; Tang S; Guo H; Wan P; Wei D; Bockholt HJ; Ehrlich S; Wolthusen RPF; King MD; Shoemaker JM; Sponheim SR; De Haan L; Koenders L; Machielsen MW; van Amelsvoort T; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; McKenna PJ; Pomarol-Clotet E; Salvador R; Corvin A; Donohoe G; Kelly S; Whelan CD; Dickie EW; Rotenberg D; Voineskos AN; Ciufolini S; Radua J; Dazzan P; Murray R; Marques TR; Simmons A; Borgwardt S; Egloff L; Harrisberger F; Riecher-Roessler A; Smieskova R; Alpert KI; Wang L; Jonsson EG; Koops S; Sommer IEC; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Stephen JM; Kwon JS; Yun J-Y; Cannon DM; McDonald C; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Busatto GF; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; Hagenaars SP; McIntosh AM; Whalley HC; Lawrie SM; Knoechel C; Oertel-Knoechel V; Staeblein M; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; McMahon A; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(5):432-440
Increased number of monocytes and plasma levels of MCP-1 and YKL-40 in first-episode psychosis
Orhan F; Schwieler L; Fatouros-Bergman H; Malmqvist A; Cervenka S; Collste K; Flyckt L; Farde L; Sellgren CM; Piehl F; Engberg G; Erhardt S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(6):433-442
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
Plaven-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Article: EJNMMI RESEARCH. 2018;8(1):74
[¹¹C]SCH23390 binding to the D₁-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis
Stenkrona P; Matheson GJ; Cervenka S; Sigray PP; Halldin C; Farde L
Article: MOLECULAR PSYCHIATRY. 2018;23(5):1244-1250
CSF GABA is reduced in first-episode psychosis and associates to symptom severity
Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2018;68:146-157
Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [¹¹C]PBR28 PET study
Tamm S; Cervenka S; Forsberg A; Estelius J; Grunewald J; Gyllfors P; Karshikoff B; Kosek E; Lampa J; Lensmar C; Strand V; Akerstedt T; Halldin C; Ingvar M; Hoglund CO; Lekander M
Article: ALZHEIMER'S AND DEMENTIA: DIAGNOSIS, ASSESSMENT AND DISEASE MONITORING. 2018;10:678-687
In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.
Mak E; Bethlehem RAI; Romero-Garcia R; Cervenka S; Rittman T; Gabel S; Surendranathan A; Bevan-Jones RW; Passamonti L; Vázquez Rodríguez P; Su L; Arnold R; Williams GB; Hong YT; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT
Article: PSYCHOLOGICAL MEDICINE. 2018;48(1):82-94
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium
Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santianez R; Crespo-Facorro B; Suarez-Pinilla P; van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jorgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Jonsson EG; Hashimoto R; Yamamori H; Fukunaga M; Jahanshad N; De Rossi P; Piras F; Banaj N; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Kraemer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: PLOS ONE. 2018;13(3):e0193770
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plaven-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Article: PEERJ. 2018;6:e5790
Serotonin 5-HT₁_A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Article: PLOS ONE. 2018;13(12):e0209584
Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
Caravaggio F; Plaven-Sigray P; Matheson GJ; Plitman E; Chakravarty MM; Borg J; Graff-Guerrero A; Cervenka S
Article: EJNMMI RESEARCH. 2017;7(1):58
Assessment of simplified ratio-based approaches for quantification of PET [¹¹C] PBR28 data
Matheson GJ; Plaven-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
Article: LECTURE NOTES IN COMPUTER SCIENCE (INCLUDING SUBSERIES LECTURE NOTES IN ARTIFICIAL INTELLIGENCE AND LECTURE NOTES IN BIOINFORMATICS). 2017;10541:371-378
Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging.
Petrov D; Gutman BA; Yu S-HJ; van Erp TGM; Turner JA; Schmaal L; Veltman D; Wang L; Alpert K; Isaev D; Zavaliangos-Petropulu A; Ching CRK; Calhoun V; Glahn D; Satterthwaite TD; Andreasen OA; Borgwardt S; Howells F; Groenewold N; Voineskos A; Radua J; Potkin SG; Crespo-Facorro B; Tordesillas-Gutiérrez D; Shen L; Lebedeva I; Spalletta G; Donohoe G; Kochunov P; Rosa PGP; James A; Dannlowski U; Baune BT; Aleman A; Gotlib IH; Walter H; Walter M; Soares JC; Ehrlich S; Gur RC; Doan NT; Agartz I; Westlye LT; Harrisberger F; Riecher-Rössler A; Uhlmann A; Stein DJ; Dickie EW; Pomarol-Clotet E; Fuentes-Claramonte P; Canales-Rodríguez EJ; Salvador R; Huang AJ; Roiz-Santiañez R; Cong S; Tomyshev A; Piras F; Vecchio D; Banaj N; Ciullo V; Hong E; Busatto G; Zanetti MV; Serpa MH; Cervenka S; Kelly S; Grotegerd D; Sacchet MD; Veer IM; Li M; Wu M-J; Irungu B; Walton E; Thompson PM
Article: NEUROIMAGE. 2017;155:344-353
Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [¹¹C] SCH-23390
Matheson GJ; Stenkrona P; Cselenyi Z; Plaven-Sigray P; Halldin C; Farde L; Cervenka S
Article: MOLECULAR PSYCHIATRY. 2017;22(6):850-856
Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [¹¹C]PBR28
Collste K; Plaven-Sigray P; Fatouros-Bergman H; Victorsson P; Schain M; Forsberg A; Amini N; Aeinehband S; Erhardt S; Halldin C; Flyckt L; Farde L; Cervenka S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):462-469
Extrastriatal dopamine D2-receptor availability in social anxiety disorder
Plaven-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Ruck C; Halldin C; Lindefors N; Cervenka S
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2017;135(5):439-447
Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium
Walton E; Hibar DP; van Erp TGM; Potkin SG; Roiz-Santianez R; Crespo-Facorro B; Suarez-Pinilla P; Van Haren NEM; de Zwarte SMC; Kahn RS; Cahn W; Doan NT; Jorgensen KN; Gurholt TP; Agartz I; Andreassen OA; Westlye LT; Melle I; Berg AO; Morch-Johnsen L; Faerden A; Flyckt L; Fatouros-Bergman H; Jonsson EG; Hashimoto R; Yamamori H; Fukunaga M; Preda A; De Rossi P; Piras F; Banaj N; Ciullo V; Spalletta G; Gur RE; Gur RC; Wolf DH; Satterthwaite TD; Beard LM; Sommer IE; Koops S; Gruber O; Richter A; Kraemer B; Kelly S; Donohoe G; McDonald C; Cannon DM; Corvin A; Gill M; Di Giorgio A; Bertolino A; Lawrie S; Nickson T; Whalley HC; Neilson E; Calhoun VD; Thompson PM; Turner JA; Ehrlich S
Article: TRANSLATIONAL PSYCHIATRY. 2017;7(4):e1104
Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study
Jayaram-Lindstrom N; Guterstam J; Haggkvist J; Ericson M; Malmlof T; Schilstrom B; Halldin C; Cervenka S; Saijo T; Nordstrom A-L; Franck J
Article: ANNALS OF NEUROLOGY. 2017;81(4):572-582
The Immune Response of the Human Brain to Abdominal Surgery
Forsberg A; Cervenka S; Fagerlund MJ; Rasmussen LS; Zetterberg H; Harris HE; Stridh P; Christensson E; Granstrom A; Schening A; Dymmel K; Knave N; Terrando N; Maze M; Borg J; Varrone A; Halldin C; Blennow K; Farde L; Eriksson LI
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;84(5):262-271
Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll-like Receptor Stimulation in Peripheral Monocytes
Orhan F; Bhat M; Sandberg K; Stahl S; Piehl F; Svensson C; Erhardt S; Schwieler L
Article: MOLECULAR PSYCHIATRY. 2016;21(8):1077-1084
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2016;54:149-157
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects
Kanegawa N; Collste K; Forsberg A; Schain M; Arakawa R; Jucaite A; Lekander M; Hoglund CO; Kosek E; Lampa J; Halldin C; Farde L; Varrone A; Cervenka S
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2016;43(1):173-183
Test-retest reproducibility of [¹¹C]PBR28 binding to TSPO in healthy control subjects
Collste K; Forsberg A; Varrone A; Amini N; Aeinehband S; Yakushev I; Halldin C; Farde L; Cervenka S
Article: JAMA PSYCHIATRY. 2015;72(7):659-667
D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants A Randomized Clinical Trial
Andersson E; Hedman E; Enander J; Djurfeldt DR; Ljotsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Ruck C
Article: NEUROIMAGE. 2015;112:225-231
Diurnal and seasonal variation of the brain serotonin system in healthy male subjects
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Article: NEUROIMAGE. 2014;102:590-595
Dopamine D1 receptor availability is related to social behavior: A positron emission tomography study
Plaven-Sigray P; Gustavsson P; Farde L; Borg J; Stenkrona P; Nyberg L; Backman L; Cervenka S
Article: SCHIZOPHRENIA RESEARCH. 2014;158(1-3):156-162
Meta-analysis of cognitive performance in drug-naive patients with schizophrenia
Fatouros-Bergman H; Cervenka S; Flyckt L; Edman G; Farde L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2013;16(4):763-769
Effects of amphetamine on the human brain opioid system - a positron emission tomography study
Guterstam J; Jayaram-Lindstrom N; Cervenka S; Frost JJ; Farde L; Halldin C; Franck J
Article: NEUROIMAGE. 2013;67:1-6
Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum
de Manzano O; Cervenka S; Jucaite A; Hellenas O; Farde L; Ullen F
Article: TRANSLATIONAL PSYCHIATRY. 2012;2(5):e120
Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder
Cervenka S; Hedman E; Ikoma Y; Djurfeldt DR; Ruck C; Halldin C; Lindefors N
Article: JOURNAL OF NEUROIMAGING. 2012;22(1):28-32
A Comparison of Gray Matter Density in Restless Legs Syndrome Patients and Matched Controls Using Voxel-Based Morphometry
Comley RA; Cervenka S; Palhagen SE; Panagiotidis G; Matthews JC; Lai RY; Halldin C; Farde L; Nichols TE; Whitcher BJ
Article: SYNAPSE. 2010;64(6):478-485
PET Studies of D2-Receptor Binding in Striatal and Extrastriatal Brain Regions: Biochemical Support In Vivo for Separate Dopaminergic Systems in Humans
Cervenka S; Varrone A; Fransen E; Halldin C; Farde L
Article: PLOS ONE. 2010;5(5):e10670
Thinking Outside a Less Intact Box: Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals
de Manzano O; Cervenka S; Karabanov A; Farde L; Ullen F
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(16):7574-7579
Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning
Karabanov A; Cervenka S; de Manzano O; Forssberg H; Farde L; Ullen F
Article: NEUROIMAGE. 2010;50(1):323-328
Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability
Cervenka S; Gustavsson JP; Halldin C; Farde L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2008;11(5):671-678
Age-related diurnal effect on D₂ receptor binding: a preliminary PET study
Cervenka S; Halldin C; Farde L
Article: NEUROIMAGE. 2008;40(3):1287-1295
Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum
Cervenka S; Backman L; Cselenyi Z; Halldin C; Farde L
Article: LAKARTIDNINGEN. 2007;104(26-27):2002-2003
[Coming generation of researchers--a question of fate for psychiatry].
Cervenka S; Reutfors J; Lundberg J; Papadopoulos F; Lundén E; Sjöström C; Björklund L
Article: BRAIN. 2006;129(Pt 8):2017-2028
Support for dopaminergic hypoactivity in restless legs syndrome:: a PET study on D2-receptor binding
Cervenka S; Palhagen SE; Comley RA; Panagiotidis G; Cselenyi Z; Matthews JC; Lai RY; Halldin C; Farde L
Article: PSYCHOPHARMACOLOGY. 2004;175(2):148-153
A cross-validation study on the relationship between central D₂ receptor occupancy and serum perphenazine concentration
Talvik M; Nordström AL; Larsen NE; Jucaite A; Cervenka S; Halldin C; Farde L
Show more

All other publications

Letter: PSYCHIATRY AND CLINICAL NEUROSCIENCES. 2022;76(10):526-527
No evidence for transmission of psychosis, bipolar or depressive disorder via hematopoietic stem cell transplantation: A Swedish registry study
Ekstrom LD; Pahnke S; Larfors G; Hagglund H; Lekander M; Edgren G; Cervenka S
Review: BJPSYCH OPEN. 2022;8(5):e159
Exhaustion disorder: scoping review of research on a recently introduced stress-related diagnosis
Lindsater E; Svardman F; Wallert J; Ivanova EN; Soderholm A; Fondberg R; Nilsonne G; Cervenka S; Lekander M; Ruck C
Review: TRANSLATIONAL PSYCHIATRY. 2022;12(1):248
Application of positron emission tomography in psychiatry-methodological developments and future directions
Cervenka S; Frick A; Boden R; Lubberink M
Corrigendum: MOLECULAR PSYCHIATRY. 2022;27(3):1855
GRK3 deficiency elicits brain immune activation and psychosis (May, 10.1038/s41380-021-01106-0, 2021)
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hokfelt T; Schalling M; Schwieler L; Cervenka S; Choi D-S; Landen M; Engberg G; Erhardt S
Editorial comment: BRAIN, BEHAVIOR, AND IMMUNITY. 2021;93:8-9
Effects of acute glial cell activation on memory performance - Implications for treatment of cognitive symptoms in neurological and psychiatric disorders
Cervenka S
Letter: BIOLOGICAL PSYCHIATRY. 2021;89(3):e5-e8
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; De Picker L; Rusjan P; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Review: THE LANCET PSYCHIATRY. 2020;7(12):1064-1074
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Meyer JH; Cervenka S; Kim M-J; Kreisl WC; Henter ID; Innis RB
Letter: NEUROIMAGE. 2020;207:116371
In response to the letter "[¹¹C]raclopride and extrastriatal binding to D2/3 receptors"
Svensson JE; Schain M; Plaven-Sigray P; Cervenka S; Tiger M; Nord M; Halldin C; Farde L; Lundberg J
Corrigendum: NATURE NEUROSCIENCE. 2020;23(2):295
Common brain disorders are associated with heritable patterns of apparent aging of the brain (vol 22, pg 1617, 2019)
Kaufmann T; van der Meer D; Nhat TD; Schwarz E; Lund MJ; Agartz I; Alnaes D; Barch DM; Baur-Streubel R; Bertolino A; Bettella F; Beyer MK; Boen E; Borgwardt S; Brandt CL; Buitelaar J; Celius EG; Cervenka S; Conzelmann A; Cordova-Palomera A; Dale AM; de Quervain DJF; Di Carlo P; Djurovic S; Dorum ES; Eisenacher S; Elvsashagen T; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Haatveit B; Haberg AK; Harbo HF; Hartman CA; Heslenfeld D; Hoekstra PJ; Hogestol EA; Jernigan TL; Jonassen R; Jonsson EG; Kirsch P; Kloszewska I; Kolskar KK; Landro NI; Le Hellard S; Lesch K-P; Lovestone S; Lundervold A; Lundervold AJ; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Norbom LB; Nordvik JE; Nyberg L; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; Richard G; Rokicki J; Sanders A-M; Selbaek G; Shadrin AA; Smeland OB; Soininen H; Sowa P; Steen VM; Tsolaki M; Ulrichsen KM; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT
Letter: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(2):502-504
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
Matheson GJ; Plaven-Sigray P; Tuisku J; Rinne J; Matuskey D; Cervenka S
Editorial comment: PSYCHOLOGICAL MEDICINE. 2019;49(10):1624-1628
Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears? A commentary on 'Neuroinflammation in schizophrenia: metaanalysis of in-vivo microglial imaging' by Marques et al.
Plaven-Sigray P; Cervenka S
Letter: SCHIZOPHRENIA RESEARCH. 2019;208:490-492
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis
Santillo AF; Lundgren S; Xu C; Orhan F; Fatouros-Bergman H; Blennow K; Zetterberg H; Portelius E; Cervenka S; Jonsson EG; Erhardt S; Engberg G
Letter: BIOLOGICAL PSYCHIATRY. 2019;85(7):e35-e39
Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?
van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R; Okada N; Yamamori H; Clark VP; Mueller BA; de Zwarte SMC; Ophoff RA; van Haren NEM; Andreassen OA; Gurholt TP; Gruber O; Kraemer B; Richter A; Calhoun VD; Crespo-Facorro B; Roiz-Santianez R; Tordesillas-Gutierrez D; Loughland C; Catts S; Fullerton JM; Green MJ; Henskens F; Jablensky A; Mowry BJ; Pantelis C; Quide Y; Schall U; Scott RJ; Cairns MJ; Seal M; Tooney PA; Rasser PE; Cooper G; Weickert CS; Weickert TW; Hong E; Kochunov P; Gur RE; Gur RC; Ford JM; Macciardi F; Mathalon DH; Potkin SG; Preda A; Fan F; Ehrlich S; King MD; De Haan L; Veltman DJ; Assogna F; Banaj N; de Rossi P; Iorio M; Piras F; Spalletta G; Pomarol-Clotet E; Kelly S; Ciufolini S; Radua J; Murray R; Marques TR; Simmons A; Borgwardt S; Schoenborn-Harrisberger F; Riecher-Roessler A; Smieskova R; Alpert KI; Bertolino A; Bonvino A; Di Giorgio A; Neilson E; Mayer AR; Yun J-Y; Cannon DM; Lebedeva I; Tomyshev AS; Akhadov T; Kaleda V; Fatouros-Bergman H; Flyckt L; Rosa PGP; Serpa MH; Zanetti MV; Hoschl C; Skoch A; Spaniel F; Tomecek D; McIntosh AM; Whalley HC; Knoechel C; Oertel-Knoechel V; Howells FM; Stein DJ; Temmingh HS; Uhlmann A; Lopez-Jaramillo C; Dima D; Faskowitz JI; Gutman BA; Jahanshad N; Thompson PM; Turner JA; Farde L; Flyckt L; Fatouros-Bergman H; Cervenka S; Collste K; Victorsson P; Engberg G; Erhardt S; Schwieler L; Malmqvist A; Hedberg M; Orhan F; Piehl F; Agartz I
Review: NEUROSCIENCE LETTERS. 2019;691:26-34
PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders
Cervenka S
Editorial comment: BRAIN, BEHAVIOR, AND IMMUNITY. 2018;74:43-44
Immune sculpting of the psychotic brain? In vivo associations between a glial cell marker and hippocampal morphology
Cervenka S
Letter: SCHIZOPHRENIA RESEARCH. 2018;199:438-441
Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients
Checa A; Malmqvist A; Flyckt L; Schwieler L; Samuelsson M; Skogh E; Cervenka S; Dahl M-L; Piehl F; Erhardt S; Wheelock CE
Letter: SCHIZOPHRENIA RESEARCH. 2018;195:406-408
First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction
Orhan F; Fatouros-Bergman H; Schwieler L; Cervenka S; Flyckt L; Sellgren CM; Engberg G; Erhardt S
Review: PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON. BIOLOGICAL SCIENCES. 2018;373(1744):20170156
Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders
Farde L; Plaven-Sigray P; Borg J; Cervenka S
Corrigendum: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(4):399
Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein (vol 3, pg 449, 2015)
van der Doef TF; Doorduin J; van Berckel BNM; Cervenka S
Review: AGEING RESEARCH REVIEWS. 2017;36:50-63
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
Review: LAKARTIDNINGEN. 2015;112:DH34
[New findings about schizophrenia can provide new diagnostics and treatment].
Schalling M; Engberg G; Andreassen O; Erhardt S; Cunningham J; Agartz I; Petrovic P; Cervenka S; Fatouros-Bergman H
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2015;3(6):449-460
Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.
van der Doef TF; Doorduin J; van Berckel BNM; Cervenka S
Letter: LAKARTIDNINGEN. 2013;110(32-33):1416-1417
[Greater clarity on scientific competence is needed].
Cervenka S; Runeson B; Lönnqvist P; Hedlund A; Grönvall KE; Flyckt L
Published conference paper: NEUROPSYCHOLOGIA. 2009;47(11):2299-2304
Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning
MacDonald SWS; Cervenka S; Farde L; Nyberg L; Backman L
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2009;19:S7-S8
Limbic dopamine D2-receptor binding and social desirability
Cervenka S; Halldin C; Farde L
Thesis / dissertation: 2008
Dopamine D2-receptor mapping in restless legs syndrome and human behaviour
Cervenka, Simon
Meeting abstract: NEUROIMAGE. 2006;31:T85
Increasing the accuracy of in vivo quantification of dopamine-D2/D3 receptor binding in the human brain by partial volume effect correction
Sovago J; Farde L; Cervenka S; Halldin C; Gulyas B
Show more

Employments

Senior Lecturer, Department of Clinical Neuroscience, Karolinska Institutet, 2021-

Degrees and Education

Docent, Karolinska Institutet, 2016
Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2008

About me

Research

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI